Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06385561
Status:
COMPLETED
Last Update Posted:
2024-04-26
First Post:
2024-04-19
Brief Title:
The Influence of Tramadol on Opioid-induced Bowel Dysfunction
Sponsor:
Asbjørn Mohr Drewes
Organization:
Aalborg University Hospital
Study Overview
Official Title:
The Influence of Tramadol on Opioid-induced Bowel Dysfunction - An Investigator Initiated Randomized Double-blinded Placebo-controlled Cross-over Clinical Trial
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Tramadol is a weak opioid and widely used to treat moderate to severe pain Stronger opioids are known to inhibit gastrointestinal motility and secretion however the effects of tramadol on gastrointestinal function remains less understood The aim of this study was to determine to what degree tramadol causes opioid-induced bowel dysfunction by using an objective design to explore gastrointestinal transit motility pattern secretion and colonic volume in a group of healthy male volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2022-500108-23-00 | CTIS | None | None |